🇮🇱 Qulipta in Israel

Qulipta (ATOGEPANT) regulatory status in Israel.

Marketing authorisation

MOH

  • Status: likely_approved

Qulipta in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in Israel

Frequently asked questions

Is Qulipta approved in Israel?

Yes. MOH has authorised it.

Who is the marketing authorisation holder for Qulipta in Israel?

AbbVie is the originator. The local marketing authorisation holder may differ — check the official source linked above.